ARROWHEAD PHARMACEUTICALS IN (ARWR)

US04280A1007 - Common Stock

23.61  +1.31 (+5.87%)

After market: 23.5 -0.11 (-0.47%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to ARWR. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 46.99. This target is 99.04% above the current price.
ARWR was analyzed by 21 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about ARWR.
In the previous month the buy percentage consensus was at a similar level.
ARWR was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 23.6123.2346.4146.9974.55 - -1.61% 96.57% 99.04% 215.76%
Up and Down Grades
Date Firm Action Rating
2024-12-03 HC Wainwright & Co. Maintains Buy -> Buy
2024-11-29 Bernstein Maintains Market Perform -> Market Perform
2024-11-27 Chardan Capital Maintains Buy -> Buy
2024-11-27 Piper Sandler Maintains Overweight -> Overweight
2024-11-27 Citigroup Maintains Neutral -> Neutral
2024-11-20 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-11 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-08 Piper Sandler Reiterate Overweight -> Overweight
2024-09-26 RBC Capital Reiterate Outperform -> Outperform
2024-09-09 Cantor Fitzgerald Reiterate Overweight
2024-09-05 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-03 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-12 B. Riley Securities Reiterate Buy -> Buy
2024-07-23 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-17 Chardan Capital Maintains Buy -> Buy
2024-07-05 HC Wainwright & Co. Maintains Buy -> Buy
2024-06-26 Chardan Capital Maintains Buy -> Buy
2024-06-20 Cantor Fitzgerald Reiterate Overweight
2024-06-11 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-05 Goldman Sachs Initiate Neutral
2024-06-03 Chardan Capital Maintains Buy -> Buy
2024-06-03 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-13 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2024-05-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-10 Chardan Capital Maintains Buy -> Buy
2024-02-08 HC Wainwright & Co. Reiterate Buy -> Buy
2024-02-07 RBC Capital Reiterate Outperform -> Outperform
2024-02-07 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2024-02-07 Citigroup Maintains Neutral -> Neutral
2024-01-16 RBC Capital Reiterate Outperform -> Outperform